Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Stoke Therapeutics Inc shares valued at $23,180,000 were purchased by Blue Horizon Enterprise Ltd on Dec 23 ’24. At $11.59 per share, Blue Horizon Enterprise Ltd acquired 2,000,000 shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Ticho Barry sold 2,586 shares, netting a total of over 33,596 in proceeds. Following the sale of shares at $12.99 each, the insider now holds 44,746 shares.
Before that, Allan Jonathan had sold 13,666 shares from its account. In a trade valued at $185,978, the GENERAL COUNSEL & CORP SEC traded Stoke Therapeutics Inc shares for $13.61 each. Upon closing the transaction, the insider’s holdings decreased to 13,666 shares, worth approximately $0.24 million.
As published in their initiating research note from Chardan Capital Markets on December 20, 2024, Stoke Therapeutics Inc [STOK] has been a Buy and the price target has been revised to $24. As of March 26, 2024, TD Cowen has increased its “Market perform” rating to a “an Outperform” for STOK.
Analyzing STOK Stock Performance
During the last five days, there has been a drop of approximately -1.82%. Over the course of the year, Stoke Therapeutics Inc shares have jumped approximately 125.86%. Shares of the company reached a 52-week high of $17.58 on 06/13/24 and a 52-week low of $4.09 on 02/13/24. A 50-day SMA is recorded $12.45, while a 200-day SMA reached $13.00. Nevertheless, trading volume fell to 0.52 million shares from 2.55 million shares the previous day.
Support And Resistance Levels for Stoke Therapeutics Inc (STOK)
According to the 24-hour chart, there is a support level at 11.08, which, if violated, would cause prices to drop to 10.83. In the upper region, resistance lies at 11.59. The next price resistance is at 11.85. RSI (Relative Strength Index) is 46.66 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.72, which suggests the price will decrease in the coming days. Percent R is at 81.19%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
